Nabil Boulos

Specialist Pharmacist in Paediatric Endocrinology & Diabetes at Southampton Children's Hospital.
Scout Leader and archer.

[Prof May Ng OBE 吳 诗 梅 @mayng888]

Our paper 'Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-A national health service pilot initiative in England' is now online via
https://t.co/4zHyPfmGYX
#closedloop #t1d #cyp #t1 #diabetestechnology

[Nabil Boulos @Nabil_Boulos]

Exciting early steps towards preserving beta cell function for as long as possible. Next step is a national screening programme...

[BSPED @BritSPED]

Tepluzimab, an anti-CD3 antibody, which has been shown to slow the onset of type 1 diabetes has now been approved by the FDA for children and adults with preclinical type 1 diabetes. It is not currently licensed in the UK and will need to be approved before it becomes available.

[Nabil Boulos @Nabil_Boulos]

BSPED guidelines for adrenal insufficiency are out: https://t.co/gNEPA3pal1
Has been amazing to be part of the working group (and getting a medal for it!) #BSPED2022

[NPPG @EditorNPPG]

Why is it so difficult to obtain repeat prescriptions in the UK for children on complex medications?

Joint @RCPCHtweets and @EditorNPPG medicines committee try to explain
https://t.co/1mXW4Azeo5

[Nabil Boulos @Nabil_Boulos]

Does diabetes technology impact the confidence of children and parents with self-management?
Finished my poster tour and looking forward to enjoying a lively 4-day conference #ISPAD2022